NREP
NEW REPRESENTATIVE AT IB RECEIVED
19/06/2025
Voltar para busca
Dado oficial do USPTO
MABQI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MABQI
ST13
US500000079322137Classe
1, 5, 40, 42, 44, 45
Pedido
79322137
Registro
6886608
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
20/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 40, 42, 44, 45
Data de depósito
11/06/2021
Data de registro
01/11/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/11/2022
Última transação
20/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
FR
Examinador
CHHINA, KARAN
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
MABQI
Representantes
Ronald M. Kachmarik Cooper Legal Group, LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 42Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical products for use in industry and science; chemical preparations for scientific useother than for medical or veterinary use; biological preparations for use in industry and science; chemical reagents other than for medical or veterinary use; chemical products for analyses in laboratories other than for medical or veterinary use; diagnostic preparations other than for medical or veterinary use; biological preparations other than for medical or veterinary use; monoclonal antibodies for scientific use; all these goods exclusively in the field of antibody generation
Classe 5
Pharmaceutical products for treatment of metabolic diseasesgastroenterological diseasesinflammatory diseasesauto-immune diseasescancer diseasesneurological diseases and infectious diseases; chemical preparations for medical or pharmaceutical use for treating metabolic diseasesgastroenterological diseasesinflammatory diseasesauto-immune diseasescancer diseasesneurological diseases and infectious diseases; medical diagnostic preparations; chemical reagents for medical or veterinary use; all these goods exclusively in the field of antibody generation
Classe 40
Custom manufacturing of pharmaceutical products for third parties; these services exclusively in the field of antibody generation
Classe 42
Research laboratory services; biological research; scientific research; clinical research; biochemical research; biotechnological research services; medical research; research in the field of pharmaceutical products; research and development of new products for third parties; technical research; engineering; technical scientific project study; research scientific project study; all these services exclusively in the field of antibody generation
Classe 44
Advisory services and information services relating to diagnostic and therapeutic properties in the field of pharmaceuticals; information and advisory services in the medical field; medical services; all these services exclusively in the field of antibody generation
Classe 45
Intellectual property licensing; licensing of patents; legal servicescopyright and industrial property right licensing; all these services exclusively in the field of antibody generation
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/03/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
23/02/2023
FIMP
FINAL DISPOSITION PROCESSED
23/02/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/02/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/11/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/11/2022
GPNX
NOTIFICATION PROCESSED BY IB
16/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/08/2022
PUBO
PUBLISHED FOR OPPOSITION
16/08/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/07/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/07/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/07/2022
RFNT
REFUSAL PROCESSED BY IB
06/06/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
16/05/2022
RFRR
REFUSAL PROCESSED BY MPU
16/05/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/04/2022
CNRT
NON-FINAL ACTION WRITTEN
31/03/2022
DOCK
ASSIGNED TO EXAMINER
02/03/2022
MAFR
APPLICATION FILING RECEIPT MAILED
16/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/10/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/10/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MABQI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.